http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EA-201891259-A1

Outgoing Links

Predicate Object
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C2601-16
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D307-77
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C403-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D301-32
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D303-46
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C403-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D301-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C403-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C309-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C309-23
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C313-04
filingDate 2016-12-09-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2019-01-31-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber EA-201891259-A1
titleOfInvention METHOD OF OBTAINING N-RETINOILTSISTINIC ACID ALKYL ETHER
abstract The method of obtaining derivatives of N-retinoylaminoalkanesulfonic acid, the method includes the use of retinoic acid, chloroformate, aminoalkanesulfonic acid selected from the group consisting of cysteic acid and its alkyl ether, cysteine sulfonic acid and its alkyl ether, homocysteic acid and its alkyl ether, homo sistimine acid and its alkyl ester, homocysteic acid and its alkyl ether, homo sistimine acid and its alkyl ester, homocysteic acid and its alkyl ether, homo sistimine acid and its alkyl ester, homocysteic acid and its alkyl ether, homo sistimine acid and its alkyl ester, homocysteic acid and its homo systeine i-cysteine sulfate acid and its alkyl ester, homocysteic acid and its h 2 esters, taurine and its derivatives, and an organic solvent and a base, mixing these components mainly in the absence of oxidizing compounds, the preparation of the reaction mixture itself comprising at least the liquid phase, where the liquid phase is one phase and the derivatives of N-retinoyl aminoalkanesulfonic acid are formed in the said liquid phase.
priorityDate 2015-12-09-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID145826768
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419595259
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419484530
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID412584818
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419489743
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID72886
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID177491
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID410508567
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419554119
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1117
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419515285
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID21226386
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID25701
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1123

Total number of triples: 32.